Technology

Medigus Ltd. Series C Warrant

$1.06
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.14 (+15.22%) As of 3:36 PM UTC today

Why Robinhood?

You can watch MDGSW and buy or sell other stocks, options, and ETFs commission-free!

About MDGSW

Medigus Ltd. engages in research and development of medical treatment for the gastrointestinal tract. Its product is the MUSE system, an endoscopic device to perform Transoral Fundoplication for the treatment of gastroesophageal reflux disease. The company was founded by Elazar Sonnenschein on December 9, 1999 and is headquartered in Omer, Israel. The listed name for MDGSW is Medigus Ltd. Series C Warrant.

CEO
Liron Carmel, MBA
Employees
—
Headquarters
Omer, HaDarom
Founded
1999
Market Cap
—
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
68.48K
High Today
$1.08
Low Today
$0.9999
Open Price
$1.08
Volume
25.07K
52 Week High
$1.23
52 Week Low
$0.0216

Collections

You May Also Like

HT-D
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure